Cite
HARVARD Citation
Emery, P. et al. (n.d.). P092 Microarray pathway analysis comparing baricitinib and adalimumab in moderate to severe rheumatoid arthritis from a phase 3 study. Annals of the rheumatic diseases. p. A52. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Emery, P. et al. (n.d.). P092 Microarray pathway analysis comparing baricitinib and adalimumab in moderate to severe rheumatoid arthritis from a phase 3 study. Annals of the rheumatic diseases. p. A52. [Online].